Inhaled Pharmaceutical Aerosols (IPAs) delivery has great potential in treatment of a variety of respiratory diseases, including asthma, pulmonary diseases, and allergies. Aerosol delivery has many advantages. It delivers medication directly to where it is needed and it is effective in much lower doses than required for oral administration.
INTRODUCTION
One of the primary functions of the lung is to provide oxygen to the body to allow for the effective exchange of oxygen and carbon dioxide between alveolar gas and pulmonary capillary blood. Recently, the lung has been recognized as an effective route for systemic drug delivery, particularly labile and refractory compounds such as peptides and proteins. Inhaled pharmaceutical aerosols (IPAs) can deliver the drugs to the blood stream by depositing the drug in alveolar regions where deposited drugs crosses the alveolar epithelium and enter blood in capillaries [1] . Inhaled medication is the most popular treatment method for respiratory disorders such as bronchial asthma.
Systemic protein or peptide drug delivery through the pulmonary airways is more effective and efficient than other routes of administration. Major concern in traditional (oral) delivery of proteins and peptides has been the low bioavailability due to the metabolizing enzymes in the digestive tract which decompose the drug rapidly. The ability to avoid contact of the drug with metabolic enzymes is a major reason to pursue pulmonary drug delivery techniques for protein and peptide materials. However the lung provides substantially greater bioavailability for macromolecules than any other port of entry to the body [2] .
Although drug delivery through the lungs is highly efficient, there are some difficulties for the aerosol particles to reach to the gas exchange region because the upper respiratory airways composed of the mouth, pharynx, and larynx filter the particles from the inspired air. Inhaled particles may be removed from the air by depositing on the surface of the airways by mechanisms such as impaction, settling, and diffusion. The deposited particle will eventually be swept up and out of the lungs with moving mucus.
The deposition mechanisms mainly depend on the size of the particle and the motion of the air moving through that airway. When a particle enters the mouth, it is subject to a sharp change in direction due to the shape of upper airways. For a larger particle, its momentum prevents it from changing direction of movement and as a result deposits in mouth and onto the back of throat. Also the inspired air stream changes direction abruptly at the upper airways, especially from pharynx to larynx, which induces instability of the air stream and increases the chances of particle deposition at the site [3] . Consequently, aerosol particles with diameters larger than 10 µm cannot reach deeper into the lungs but instead deposit in the upper airway (mouth, pharynx, or larynx). In contrast, particles smaller than 1 µm in diameter tend to be inhaled and then exhaled right back without deposition in the airways [4] .
Thus the inhaled aerosol must consist of particles in a certain size range with specific inhaling air flow rate when the deeper lung is the target for the aerosol delivery. Therefore IPAs are usually designed to produce drug particles having the diameter between 1-5 µm which is optimal for delivery of drug into the deeper lung. As in Figure 1 , Patton et al. have experimentally shown that most inhaled aerosol particles with aerodynamic diameter about 1-5 µm, if slowly and deeply inhaled with 5 second breath hold, can be deposited in the peripheral regions that are rich in alveoli [5] . In this study, we use computational fluid dynamics (CFD) to investigate the effects of several different inhaling rates with breath-holding pause on the aerosol (dp=0.5-5 µm) deposition in a 3 dimensional human upper airway model extending from the mouth to the 3 rd generation of trachea. CFD allows the analysis of fluid flow problems in detail more quickly with lower cost of money and less possible risks than other experiments. The purpose of this research is to investigate the effect of inhaling patterns on particle (dp=0.5-5 µm) deposition in our 3 dimensional upper airway lung model using CFD. More detail about the inhaling patterns will be described in section 2.2.
The oral airway model is three dimensional and non-planar. The dimensions of the model are adapted from a human cast reported by Cheng et al. [6] and Weibel [7] . The air flow is assumed to be unsteady, laminar, and incompressible. The investigation is carried out by computational fluid dynamics (CFD) technique using the software Fluent 6.2. The userdefined-function (UDF) is employed to simulate the cyclic inspiratory flows for different IPA inhalation patterns. Jin et al. [8] and Sosnowski et al. [9] performed similar particle deposition simulations with Fluent.
THEORY 2.1 Geometry
As shown in Fig.2 , the present upper airway model includes the oral cavity, pharynx, larynx, trachea, and bifurcation lung airway model representing generations G0 (trachea) to G3 after Weibel [7] . The dimensions of the oral airway model were adapted from a human cast as reported by Cheng et al. [6] . An average hydraulic diameter was calculated from Cheng's model and used to model oral airway from mouth to trachea region as Zhang et al. [11] described. The dimensions of third-generation airway model are similar to those given by Weibel [7] for an adult with a lung volume of 4800 ml. The geometric data of the 3D airway model are provided in Tables 1 and 2 . In Table 2 , the bifurcation angle represents the angle between bifurcations at each generation while the plane angle represents the angle between plane and bifurcations. 
Sinusoidal inhalation
In order to investigate the effect of different inhaling rates on the aerosol (dp=0.5-5 µm) deposition in the upper airway model, realistic transient inhaling patterns are simulated to compare with the experimental data from Patton and Byron (2007) . To obtain a transient velocity waveform of IPA inhalation, we selected air volume of 3 L which a normal person can inhale after a forced breath-out. Then, a waveform was computed by developing sine wave functions using the air volume (3 L) and different inhaling time.
To see the influence of different inlet air flow conditions on inhaled air flow field and on the particle trajectories, we chose 1 second, 2 seconds, 3 seconds, 4 seconds, and 5 seconds of inhalation times. The different inhaling times are chosen from the recommended IPAs inhaling procedure presented by Sloane [12] (see Table 3 ). The Sinusoidal inhaling functions for the five different inhaling patterns presented in Table 4 . The inhaling wave forms are shown in Fig.3 . Breathe holding for 5-10 second is recommended since it will allow the inhaled particles to settle down and deposit on the lung surfaces. However, our data show that the breathe holding does not affect additional particle deposition in our 3D lung model. This is because all the particles are either deposited or escape our airway model before the breath holding takes place. Thus we have eliminated the breathe holding procedure in this simulation. 
Governing equations
For 3D unsteady, incompressible and laminar flow with constant properties, the gas transport is governed by the Navier-Stokes equations given as (Munson et al. [13] )
where V r is the velocity vector, P is the pressure, ρ is the fluid density, υ is the fluid kinematic viscosity, and g r is the gravitational acceleration.
To model the air flow in the turbulent flow regime, k-ω model of Kleinstreuer and Zhang [10] was employed.
(Turbulent kinetic energy equation, k) At the mouth inlet, the initial values for k and ω were assigned using the following empirical relation
Where l is the turbulence length scale. (Fluent Inc. [14] ). Applying Newton's second law to each individual particle and assuming no interaction between particles and between particles and wall yield,
where
is the drag force per unit particle mass (acceleration due to drag) and 24 Re 18
Here, V is the fluid phase velocity, V p is the particle velocity, μ is the dynamic viscosity of the fluid, ρ is the fluid density, ρ p is the density of the particle, and d p is the particle diameter. Re r is the relative Reynolds number, which is defined as
The drag coefficient, C D is calculated using the following expression: where a i are constants that apply to smooth spherical particles over several ranges of Re given by Morsi and Alexander [15] .
NUMERICAL METHOD 3.1 Mesh Generation
The computational mesh was generated by GAMBIT. The geometry of the model in section 2.2 was created and meshed with tetrahedral cells for the better flexibility in adapting to curved surfaces. In the radial direction, a much finer mesh was implemented around the surfaces of wall to improve solution by refining the grid to better resolve the flow details. The grid adaptation was performed based on velocity gradient so that finer grids could be generated in locations where there was a large change in velocity, such as along the walls. Chen and Kim [16] have used similar grad adaptation technique for their 3D airways model from G3 to G5. The final mesh of the airway model contains about 311,000 cells.
Boundary conditions
Sinusoidal velocity waveforms discussed in Section 2.2 were imported for inlet boundary conditions to simulate aerosol inhalation patterns. In the present simulations, about 20,000 of uniformly distributed aerosol particles (d P =0.5-5 μm, density=1000kg/m 3 ) are released at inlet for 0.5 seconds. Zero pressure at the outlet is assumed based on observations of Nowak et al. [18] that are the constant pressure outlet boundary conditions would yield an insignificant deviation from outflow approximation in particle tracking calculations.
Copyright © 2008 by ASME Downloaded 29 Jul 2012 to 128.59.46.66. Redistribution subject to ASME license or copyright; see http://www.asme.org/terms/Terms_Use.cfm A particle was assumed to be trapped on a wall surface when it hit the wall and the particle tracking was terminated.
Velocity Field Calculations
The numerical solution of fluid flow equations, i.e. Eqs.(1) and (2), were carried out employing a user-enhanced program, Fluent 6.2, which is developed based on a finite volume technique and pressure-based segregated solution algorithms. First-order implicit integration scheme was used to evaluate velocity values at a future time. The SIMPLE algorithm with underrelaxation was employed to solve the flow equations. The sets of linearized and discretized equations for all variables were solved using algebraic multigrid methods.
Particle Trajectory Calculation
The particle trajectory equation, Eq. (6), was solved using same program. Fluent predicts the trajectory of discrete phase particles by integrating the force balance on each particle, which is written in a Lagrangian reference frame. After each iteration for each particle, the information about position, time, and 3 components of velocity as well as the speed with which the particles cross the control volume boundaries was obtained. Particles of specific sizes were introduced in a uniform distribution at the inlet face of the computation domain, and tracked through the geometry until they met one of three fates: (1) trapping on a surface by collision, (2) escape from the domain through one of the outlet faces, or (3) continued suspension in the flow. The fate of the particles were then recorded and summarized as a particle history file.
Both the flow field and particle trajectory calculations were performed primarily on the 3.39 GHz Pentium® D processor and took a few hours per calculation. The appropriate time step to calculate flow fields and particle trajectories was determined to reduce the possibility of losing information by selecting to large time step. A small time step used for relatively slower inhalations (3-5 seconds) was 0.01 seconds and for faster inhalations (1-2 seconds) was 0.001 seconds The solution of the flow field at each time step was assumed to be converged when the continuity residual <10 -6 .
COMPUTER MODEL VALIDATION
The present simulation of air flow field and particle trajectories using the computational fluid dynamics model has been validated with various experimental data for bifurcations under laminar and transient flows (Cheng et al. [6] ). Experimental observations and theoretical predictions show good agreements which make us confident our computational model is accurate to analyze the transient laminar fluid flow and particle tracking in three dimensional oral cavity and airway bifurcations.
RESULTS AND DISCUSSION

Air velocity fields and particle trajectories
One needs to understand the airflow structures in the human airways to be able to analyze particle transport and deposition because the air flow is one of the important factors which affect the particle's motion in the airways. In this section, unsteady air flow velocity field in the airway model for an inhaling pattern will be discussed at selected time as well as its effect on particle motion distribution in the airway.
Most particle deposition occurs when airflow accelerates and the airflow velocity is at peak. The contour of velocity field and secondary velocity vectors in the airway model for selected times are t 1 =1 sec (airflow accelerating) and t 2 =2.5 sec (peak airflow velocity) shown in Fig. 4 . This depicts airflow motion for the case of 5 second inhalation. To be able to observe secondary flows which are important in aerosol transport and particle deposition cross sections are selected at curvatures in the airway model As shown in Fig. 4 , midplane velocity significantly increases from time t 1 to t 2 . However, in both cases, maximum velocities are presented near the inner wall of curvature for both cases. Chen and Kim [16] and Zhang et al. [17] also noticed the similar flow phenomena in their 3D airway model (G3-G5).
If the secondary flow is strong enough, the particle cannot follow the streamlines and maybe pulled away from the stream. The secondary flow merely exist in a-a' both at time t 1 and t 2 but it generally increases as airflow passes through the airway due to the curvatures. After the airflow passes almost 90º turn at pharynx region (b-b'), strong secondary motion appears. This secondary flow wraps around the top and bottom of the airway. The secondary flow at c-c' appears diverging from the inner wall of the curvature. The airflow changes its direction to opposite after it passes another curvature (d-d'). The intensity of secondary flow decreases between c-c' and dd' due to the minor bend of the airway.
These abrupt direction changes of inhaled airflow will lead the particles to deposit on the wall surface in this region because the particles' inertia prevents them from following the airflow. Hence, larger particles which have higher inertia due to size tend to deposit this region.
Figure5. Velocity magnitude vectors and contour in midplane of pharynx and larynx regions (5 second inhalation, t=t 2 ) Figure 5 depicts the velocity magnitude vectors and contour at pharynx and larynx region. The magnitude of velocity vectors is greater at the higher velocity contour regions that are inner wall of curvatures. The flow separation at outer wall of d-d' cross section surface is more clearly seen and the velocity vectors at the flow separation region display eddy motions. Even though most particles will follow the main airflow stream that flow downward, some particles near the eddy will swept up and may deposit on that region. As shown in Figs. 4 and 5, the velocities of the air increase rapidly in the larynx. On the other hand, the sharply curving of the pipe makes the turbulence intensity rise dramatically (see Fig. 6 ). Also the action of the secondary flows is intensified with the turbulence intensity increasing and many particles deposit on the wall (Jin et al. [8] ). Particle path lines are useful to illustrate the impact of airflow on particle motion. Note that Fluent stops calculating the pathline for a particle when it hits a wall surface. Figure 7 shows pathlines of two particles which are released at different locations at inlet. The particle with yellow pathline passes the upper airways smoothly while the particle with blue pathline is trapped in the eddy at the flow separation region and deposited on the surface. Figure 8 depicts velocity magnitude vectors with overlaid velocity magnitude contour at Carina regions (first bifurcation) just after the Trachea and particle pathlines at selected regions. As shown in Fig. 8 (Region A) , the velocity vectors move toward carina regions at the bifurcations which mean airflow tends to move in the same direction. Also particles which have not deposited in upper region keep following the streamlines and some particles that are not able to make turns at the carina region and will hit on the surface to deposit due to their inertia.
Due to sharp angle, flow separation occurs and the eddying motion of airflow is observed at the outer wall of the first left daughter branch in Fig. 8 (Region B) . If a particle enters in this region, it will have a chance to deposit on the outer wall surface. The particle pathlines show that most particles follow downstream since they are stronger than the secondary flow. However few particles are captured in the eddy and travel with the secondary motion of the airflow.
Particles which have not deposited on our 3 dimensional upper airway model will keep following the air stream to reach deeper into the lung (see Fig. 9 ). More particles pass through daughter branches running downward. Even though airflow rates through exits of each daughter branches are set to be equal as a boundary condition, most particles travel through downward branches. The downward branches require less turns to the particles so it is easier for them to travel through. Also the gravity force helps the particles to move downwards. 
Particle deposition pattern
The fate of the particles (deposited, escaped, or suspended) was recorded and summarized as a particle history file in Fluent. The number of particle deposited in our upper airway model for each simulation was collected. The percentage of inhaled aerosol particles deposited in realistic 3D upper airway as a function of particle diameter and inhaling time is plotted in Fig.10 Figure 10 . Inhaling time vs. aerosol particle deposition fraction
The number of particle deposited in our upper airway model generally increases with particle size mostly due to inertial impaction. Especially 5µm particles with 1 second inhalation has deposition fraction higher than 50%. The deposition fractions for particles with 5 second inhalation are about 18-20% and gradually increase as particle size increase. Our computer simulation predicts a little bit higher deposition fraction but this trend has also been reported by Patton and Byron [5] (see Fig. 1 ). Deposition percentage of aerosol particles in mouth and throat region in their human respiratory tract model increase from about 10 % to 19% as particle size increases from 2 µm to 5 µm. The disparity is due to the difference in geometry between respiratory models.
Inhaling time greatly influences deposition fraction especially for 1 and 2 second inhalation. Since volume of air inhaled for each inhaling pattern is 3 L, shortening inhaling time will result in higher velocity of inhaled airflow. As one can see in Fig. 10, for smaller particles (0.5-2µm) , velocity of the inhaling airflow does not affect their deposition in the airway model. Particles with diameter of 1µm are collected with a low overall deposition percentage (Sosnowski et al. [9] ). However, for larger particles (3-5µm) it becomes important as particle size increases especially for faster inhalation (1 and 2 second inhalation). Cheng et al. [19] also reported that the particle deposition increased with an increasing flow rate, suggesting that impaction could be the dominant deposition mechanism for particle >0.9µm in the human upper airways. Also Li et al. [20] found that particle deposition depends on the complex geometry and flow rate magnitude.
CONCLUSION
By analyzing aerosol deposition in realistic human upper airway model that resemble parts of the respiratory tract (oral cavity, pharynx, larynx, trachea, and bronchi), we have developed that inhaled pharmaceutical aerosol particle deposition, from which a good understanding of deposition in the respiratory tract has been produced. Our airway model of aerosol particle deposition produces results that are in good agreement with experimental results in the literature. This model can be useful in the development of inhaled pharmaceutical aerosol devices, particularly when aerosol drug delivery into alveoli region is the target. Also the model can give insight of the importance of aerosol particle size and inhaling pattern to improve aerosol drug delivery.
The following conclusions can be drawn from the experimentally validated aerosol particle deposition model. a. When an aerosol enters the mouth respiratory tract, its particles experience abrupt changes in direction due to the multi-curvature geometry of the upper respiratory tract. b. Direction of the secondary flow changes as the airflow passes curvature. Intensity of the secondary flow is strong after the first bend at pharynx and becomes weaker after larynx. c. In flow separation, a particle can be trapped in the eddy and deposit on the surface. d. Particle deposition fraction generally increases as particle size and inhaling airflow velocity increase. Slow inhalation (3-5 seconds) reduces particle deposition in the upper airway, consequently more particles can be delivered to deeper lung tissues.
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